Latest filing published 02 Jun 2022 for Iovance Biotherapeutics, INC., €49k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +4.7%Entry US$7.85 · Close at T+365 US$8.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael Weiser: trading record in brief
This profile gathers the share dealings of Michael Weiser across 6 companies, led by Alaunos Therapeutics, Inc., Chelsea Therapeutics International, Ltd. and TG Therapeutics, Inc. In total, 54 filings cover trades dated from 26 May 2006 to 31 May 2022.
Both buying and selling appear: 16 purchases worth €91k, against 1 sale worth €70k. The net balance comes to €21k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 28 share grants and 4 option exercises. In 2022 alone, the filings show 2 purchases and no sales.
Half of the purchases are above €1,946 and half below.
The newest entry dates from 2 June 2022: an open-market purchase of €49k, in Iovance Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Weiser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,813 shares@ US$6.8078.2% of flowCommon StockSEC:0001104659-22-067761:1Canonical exit: 29 Aug 2022 (T+90)
- 2,187 shares@ US$6.79100.0% of flowCommon StockSEC:0001104659-22-067761:0Canonical exit: 29 Aug 2022 (T+90)
- 17,258 shares0Common StockSEC:0001209191-18-001023:0
- 6,021 shares@ US$4.144.7% of flowCommon StockSEC:0001209191-18-001023:1
- 20,000 shares@ US$2.7310.5% of flowCommon StockSEC:0001209191-17-065008:0
- 12,325 shares@ US$4.4310.5% of flowCommon StockSEC:0001209191-17-065008:1
- 15,000 shares@ US$4.8514.7% of flowCommon StockSEC:0001209191-17-039824:0
- 13,300 shares@ US$5.4714.7% of flowCommon StockSEC:0001209191-17-039824:1
- 9,331 shares@ US$5.3510.7% of flowCommon StockSEC:0001209191-17-000952:1
- 17,204 shares0Common StockSEC:0001209191-17-000952:0
- 15,000 shares@ US$5.0115.0% of flowCommon StockSEC:0001209191-16-115072:0
- 10,751 shares@ US$8.8819.1% of flowCommon StockSEC:0001209191-16-115072:1
- 26,661 sharesCommon StockSEC:0001209191-16-088677:1
- 2,047 sharesCommon StockSEC:0001209191-16-088677:0
- 2,051 shares@ US$5.03Common StockSEC:0001209191-15-000220:0
- 2,047 shares@ US$5.07Common StockSEC:0001209191-15-000220:1
- 450,178 sharesCommon StockSEC:0001144204-14-039649:0
- 27,500 shares@ US$6.50Common StockSEC:0001144204-14-039649:1
- 27,500 sharesCommon StockSEC:0001144204-14-039649:2
- 5,854 shares@ US$4.34Common StockSEC:0001209191-14-000763:0
- 17,546 shares0Common StockSEC:0001209191-13-001334:0
- 1,904 shares@ US$4.21Common StockSEC:0001209191-13-001334:1
- 100 shares@ US$1.32Common StockSEC:0001181431-12-035049:0Canonical exit: 3 Sept 2012 (T+90)
- 4,900 shares@ US$1.32Common StockSEC:0001181431-12-035049:1Canonical exit: 3 Sept 2012 (T+90)
- 35,566 shares@ US$3.93Common StockSEC:0001209191-12-031699:0
25 of 51 declarations
